WeVote

Bill

Bill

36-0093

An act appropriating $1,500,000 from the General Fund of the Treasury of the Government of the Virgin Islands to the Virgin Islands Diabetes Center of Excellence for staffing and operations within the Territory

2025-2026 Regular Session

Allocates $1.5 million from the General Fund to the Virgin Islands Diabetes Center of Excellence for staffing and operations, boosting diabetes services.

Introduced
0
WeVote Research Nonpartisan
Bill Summary · 36-0093

Summary of Bill 36-0093

Overview

Bill 36-0093 is an act that would appropriate $1,500,000 from the General Fund of the Treasury of the Government of the Virgin Islands to the Virgin Islands Diabetes Center of Excellence. The funds are designated for staffing and operations within the Territory. The bill is categorized as introduced, with a formal legislative path that moved through assignments and referrals in April–May 2025.

Key Provisions

  • Appropriation Amount: $1,500,000
  • Source of Funds: General Fund of the Treasury of the Government of the Virgin Islands
  • Recipient: Virgin Islands Diabetes Center of Excellence
  • Purpose: For staffing and operations within the Territory
  • Duration/Scope Details: The bill summary provided does not specify whether the funding is one-time or ongoing, nor does it itemize specific line-items or programs within the Center.

Fiscal Impact

  • Immediate Effect: Transfers $1.5 million from the General Fund to the Virgin Islands Diabetes Center of Excellence.
  • Budget Considerations: The appropriation will reduce available General Fund resources by the stated amount unless offset by other changes. The absence of duration or annualization details means the long-term fiscal obligation is not fully defined in the summary.

Affected Parties

  • Primary Beneficiary: Virgin Islands Diabetes Center of Excellence, which would receive funding to support staffing and operational needs.
  • Governing Bodies: Government of the Virgin Islands; General Fund as the funding source.
  • Public Impact: Potential improvements in diabetes-related services, programs, and capacity resulting from enhanced staffing and operations. Specific service outcomes are not detailed in the transaction.

Legislative Timeline and Status

  • ** April 15, 2025:** Bill received and assigned (per actions listed).
  • ** May 9, 2025:** To Senate (referred to the Senate for consideration).
  • ** May 19, 2025:** Status shows as introduced.
  • Note: The record shows a discrepancy between the “Introduced” date field (April 15) and the later action indicating introduction on May 19. The documented actions indicate initial processing in mid-April with subsequent referral and formal introduction in May.

Additional Observations

  • The summary provided does not include any additional policy changes beyond the appropriation. If enacted, the bill would become a funding mechanism for the Center’s staffing and day-to-day operations, subject to standard budgetary processes and any further legislative approvals.

If you’d like, I can add a short comparison to typical one-time vs. ongoing appropriations or draft potential amendments that could clarify duration, reporting, or accountability for the funding.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.